These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6533499)

  • 41. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer.
    Epenetos AA; Lavender JP; Kenemans P; Poels L
    J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157
    [No Abstract]   [Full Text] [Related]  

  • 42. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.
    Perkins AC; Pimm MV; Powell MC
    Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
    J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pelvic mass with changes in intestinal habits and rectorrhagia].
    García Pérez M; Yébenes Díaz ML; de Diego Rey P; Martín Peinador A; Mata Olmo I; Ortega Medina L
    Rev Clin Esp; 1989 Oct; 185(5):265-7. PubMed ID: 2692103
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunoscintigraphy in oncology exemplified by ovarian cancer].
    Pateisky N
    Gynakol Rundsch; 1989; 29 Suppl 3():40-3. PubMed ID: 2696699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases].
    Baum RP; Hertel A; Hör G
    Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of pelvic invasion of uterine and ovarian cancer by phlebography].
    Snelling M; Kendall M
    J Radiol Electrol Med Nucl; 1969 May; 50(5):261-4. PubMed ID: 5401309
    [No Abstract]   [Full Text] [Related]  

  • 50. Nonantigen-specific tissue localization of monoclonal antibodies.
    Massuger L; Claessens R; Kenemans P; Hanselaar T; Corstens F
    J Nucl Med; 1990 Aug; 31(8):1438. PubMed ID: 2256995
    [No Abstract]   [Full Text] [Related]  

  • 51. I-131 uptake in an ovarian tumor: differential diagnosis for abdominal I-131 uptake.
    Kraft O; Mrhac L; Sirucek P; Dvorackova J; Chmelova J; Graf P; Sevcik L
    Clin Nucl Med; 2009 Jun; 34(6):390-2. PubMed ID: 19487856
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Corstens FH
    Eur J Obstet Gynecol Reprod Biol; 1991 Aug; 41(1):47-63. PubMed ID: 1748227
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoclonal antibodies for successful tumour imaging.
    Burchell J; Taylor-Papadimitriou J; Granowska M; Britton K
    Behring Inst Mitt; 1984 May; (74):87-93. PubMed ID: 6541035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer.
    Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M
    Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Combined use of iodine 123 and technetium 99m pertechnetate in a recurring struma ovarii].
    Serafini A; Mejia J
    Rev Interam Radiol; 1978 Jan; 3(1):53-6. PubMed ID: 644187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biodistribution, pharmacokinetics and imaging of 131I-labeled HMD4 human McAb in human ovarian carcinoma xenograft in nude mice].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):80-3, 123. PubMed ID: 2364795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Radioimmunoscintigraphy in ovarian cancer: theoretical principles and clinical experiences].
    Gitsch E; Pateisky N
    Arch Gynecol Obstet; 1987; 242(1-4):365-70. PubMed ID: 3688958
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comprehensive diagnosis of cancer of the ovaries].
    Korsunskiĭ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
    Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of ovarian cancer with radiolabelled antibodies.
    Granowska M; Britton KE; Mather S; Crowther M; Nimmon CC; Bomanji J; Shepherd J
    Int J Rad Appl Instrum B; 1989; 16(6):653-7. PubMed ID: 2691459
    [No Abstract]   [Full Text] [Related]  

  • 60. Resection guided by antibodies (REGAJ) a reappraisal after 10 years.
    Jäger W; Ackermann S
    Int J Biol Markers; 1998; 13(4):221-3. PubMed ID: 10228905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.